Literature DB >> 34344960

Detection of early changes in the post-radiosurgery vestibular schwannoma microenvironment using multinuclear MRI.

Daniel Lewis1,2,3, Damien J McHugh4, Ka-Loh Li5, Xiaoping Zhu5, Catherine Mcbain6,7, Simon K Lloyd8,9, Alan Jackson5, Omar N Pathmanaban10,6,11, Andrew T King10,6,12, David J Coope10,6,13.   

Abstract

Stereotactic radiosurgery (SRS) is an established, effective therapy against vestibular schwannoma (VS). The mechanisms of tumour response are, however, unknown and in this study we sought to evaluate changes in the irradiated VS tumour microenvironment through a multinuclear MRI approach. Five patients with growing sporadic VS underwent a multi-timepoint comprehensive MRI protocol, which included diffusion tensor imaging (DTI), dynamic contrast-enhanced (DCE) MRI and a spiral 23Na-MRI acquisition for total sodium concentration (TSC) quantification. Post-treatment voxelwise changes in TSC, DTI metrics and DCE-MRI derived microvascular biomarkers (Ktrans, ve and vp) were evaluated and compared against pre-treatment values. Changes in tumour TSC and microvascular parameters were observable as early as 2 weeks post-treatment, preceding changes in structural imaging. At 6 months post-treatment there were significant voxelwise increases in tumour TSC (p < 0.001) and mean diffusivity (p < 0.001, repeated-measures ANOVA) with marked decreases in tumour microvascular parameters (p < 0.001, repeated-measures ANOVA). This study presents the first in vivo evaluation of alterations in the VS tumour microenvironment following SRS, demonstrating that changes in tumour sodium homeostasis and microvascular parameters can be imaged as early as 2 weeks following treatment. Future studies should seek to investigate these clinically relevant MRI metrics as early biomarkers of SRS response.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34344960     DOI: 10.1038/s41598-021-95022-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

Review 1.  An update on the diagnosis and treatment of vestibular schwannoma.

Authors:  Jane Halliday; Scott A Rutherford; Martin G McCabe; Dafydd G Evans
Journal:  Expert Rev Neurother       Date:  2017-11-07       Impact factor: 4.618

2.  Evolution in Management Trends of Sporadic Vestibular Schwannoma in the United States Over the Last Half-century.

Authors:  Stephen A Chan; John P Marinelli; Debbie L Hahs-Vaughn; Chad Nye; Michael J Link; Matthew L Carlson
Journal:  Otol Neurotol       Date:  2021-02-01       Impact factor: 2.311

3.  Gamma Knife radiosurgery for vestibular schwannomas: evaluation of tumor control and its predictors in a large patient cohort in The Netherlands.

Authors:  Stijn Klijn; Jeroen B Verheul; Guus N Beute; Sieger Leenstra; Jef J S Mulder; Henricus P M Kunst; Patrick E J Hanssens
Journal:  J Neurosurg       Date:  2015-10-02       Impact factor: 5.115

4.  Influence of pretreatment growth rate on Gamma Knife treatment response for vestibular schwannoma: a volumetric analysis.

Authors:  Patrick P J H Langenhuizen; Svitlana Zinger; Patrick E J Hanssens; Henricus P M Kunst; Jef J S Mulder; Sieger Leenstra; Peter H N de With; Jeroen B Verheul
Journal:  J Neurosurg       Date:  2018-11-01       Impact factor: 5.115

5.  Tumor pseudoprogression following radiosurgery for vestibular schwannoma.

Authors:  Caroline Hayhurst; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2011-10-25       Impact factor: 12.300

Review 6.  Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization.

Authors:  Andrea H Yeung; Michael E Sughrue; Ari J Kane; Tarik Tihan; Steven W Cheung; Andrew T Parsa
Journal:  Neurosurg Focus       Date:  2009-12       Impact factor: 4.047

7.  Results of surgery following stereotactic irradiation for acoustic neuromas.

Authors:  W H Slattery; D E Brackmann
Journal:  Am J Otol       Date:  1995-05

8.  Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience.

Authors:  Bruce E Pollock
Journal:  Neurosurgery       Date:  2006-02       Impact factor: 4.654

9.  Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene.

Authors:  D Gareth Evans; Andrew J Wallace; Claire Hartley; Simon R Freeman; Simon K Lloyd; Owen Thomas; Patrick Axon; Charlotte L Hammerbeck-Ward; Omar Pathmanaban; Scott A Rutherford; Mark Kellett; Roger Laitt; Andrew T King; Jemma Bischetsrieder; Jaishri Blakeley; Miriam J Smith
Journal:  Laryngoscope       Date:  2018-10-16       Impact factor: 3.325

10.  Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.

Authors:  Daniel Lewis; Federico Roncaroli; Erjon Agushi; Dominic Mosses; Ricky Williams; Ka-Loh Li; Xiaoping Zhu; Rainer Hinz; Ross Atkinson; Andrea Wadeson; Sharon Hulme; Helen Mayers; Emma Stapleton; Simon K L Lloyd; Simon R Freeman; Scott A Rutherford; Charlotte Hammerbeck-Ward; D Gareth Evans; Omar Pathmanaban; Alan Jackson; Andrew T King; David J Coope
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

View more
  2 in total

1.  Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma.

Authors:  Johannes Wach; Ági Güresir; Valeri Borger; Patrick Schuss; Albert Becker; Christoph Coch; Marie-Therese Schmitz; Michael Hölzel; Marieta Toma; Ulrich Herrlinger; Hartmut Vatter; Erdem Güresir
Journal:  J Neurooncol       Date:  2021-12-09       Impact factor: 4.130

Review 2.  Multinuclear MRI in Drug Discovery.

Authors:  Dorota Bartusik-Aebisher; Zuzanna Bober; Jolanta Zalejska-Fiolka; Aleksandra Kawczyk-Krupka; David Aebisher
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.